Evaluation of copolymyers of N-isopropylacrylamide and 2-dimethyl(aminoethyl)mechacrylate in non-viral and adenoviral vectors for gene delivery to nasopharyngeal carcicoma

International Journal of Nanomedicine

Volumn 2, Issue 3, 2007, Pages 461-478

  Moselhy, Jim ^a   Sarkar, Swapna ^a   Chia, Maria C ^b   Mocanu, Joseph D ^b   Taulier, Nicolas ^a   Liu, Fei Fei ^b,c   Wu, Xiao Yu ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cytotoxicity; Polymer DNA complex; Polymer modified adenovirus; Polymers of 2 dimethyl(aminoethyl) mechacrylate N isopropylacrylamide; Transduction efficiency

Indexed keywords

ADENOVIRUS VECTOR; COPOLYMER; PLASMID DNA; POLY(N ISOPROPYLACRYLAMIDE); POLYELECTROLYTE; POLY[2 (DIMETHYLAMINO)ETHYL METHACRYLATE]; ACRYLIC ACID RESIN; DRUG CARRIER; METHACRYLIC ACID DERIVATIVE; NYLON; POLY N ISOPROPYLACRYLAMIDE; POLY(2 (DIMETHYLAMINO)ETHYL METHACRYLATE); POLY(2-(DIMETHYLAMINO)ETHYL METHACRYLATE); POLY-N-ISOPROPYLACRYLAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENE THERAPY; CIRCULAR DICHROISM; CONTROLLED STUDY; DNA BINDING; DNA STRUCTURE; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; NONVIRAL GENE DELIVERY SYSTEM; POLYMERIZATION; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; ADENOVIRUS; CHEMISTRY; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETICS; METHODOLOGY; NASOPHARYNX TUMOR; PLASMID; TUMOR CELL LINE;

ADENOVIRIDAE; MIRIDAE;

ACRYLIC RESINS; ADENOVIRIDAE; CELL LINE, TUMOR; DRUG CARRIERS; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; METHACRYLATES; NASOPHARYNGEAL NEOPLASMS; NYLONS; PLASMIDS; TRANSFECTION;

EID: 38449089429     PISSN: 11769114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Alemany R, Suzuki K, Curiel DT. 2000. Blood clearance rates of adenovirus type 5 in mice. J Gen Virology, 81(Pt11):2605-9.
2. Baker A, Saltik M, Lehrmann H, Killisch I, Mautner V, Lanini G, Christofori G, Cotten M. 1997. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther, 4(8):773-82.
3. Baker A, Cotten M. 1997. Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier. Nucleic Acids Res, 25(10):1950-6.
4. Bilbao G, Gomez-Navarro J, Curiel DT. 1998. Targeted adenoviral vectors for cancer gene therapy. Adv Exp Med Biol, 451:365-74.
5. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA, 92(16):7297-301.
6. Brazel CS, Peppas NA. 1995. Synthesis and characterization of thermo- and chemomechanically responsive Poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. Macromolecules, 28(24):8016-20.
7. Cherng JY, Talsma H, Crommelin DJ, Hennink WE. 1999. Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems. Pharm Res, 16(9):1417-23.
8. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer, 83(1):121-6.
9. Chillon M, Lee JH, Fasbender A, Welsh MJ. 1998. Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro. Gene Ther, 5(7):995-1002.
10. Conwell CC, Huang L. 2005. Recent advances in non-viral gene delivery. Adv Genet, 53:3-18.
11. Croyle MA, Chirmule N, Zhang Y, Wilson JM. 2001. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung. J Virology, 75(10): 4792-801.
12. Croyle MA, Chirmule N, Zhang Y, Wilson JM. 2002. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum Gene Ther, 13(15):887-900.
13. Diebold SS, Lehrmann H, Kursa M, Wagner E, Cotton M, Zenke M. 1999. Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection. Hum Gene Ther, 10(5):775-86.
14. Di Nicola M, Carlo-Stella C, Milanesi M, Magni M, Longoni P, Mortarini R, Anichini A, Tomanin R, Scarpa M, Gianni AM. 2000. Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex. Br J Haematol, 111(1):34-50.
15. Douglas JT, Curiel DT. 1997. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors. Neuromuscul Disord, 7(5):284-98.
16. Egoyan RV, Gregoryan VV, Safaryan GE. 1985. Determination of Mark-Houwink Equation Constant for dimethyl(aminoethyl)methacrylate in different solvents. Arm Chem J, 38(10):611-614.
17. Eto Y, Gao J-Q, Sekiguchi F, Kurachi S, Katayama K, Maeda M, Kawasaki K, Mizuguchi H, Hayakawa T, Tsutsumi Y, Mayumi T, Nakagawa S. 2004. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability. J Gene Med, 7(5):604-12.
18. Ewert K, Evans HM, Ahmad A, Slack NL, Lin AJ, Martin-Herranz A, Safinya CR. 2006. Lipoplex structures and their distinct cellular pathways. Adv Genet, 53:119-55.
19. Fasbender A, Zabner J, Chillón M, Moninger TO, Puga AP, Davidson BL, Welsh MJ. 1997. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem, 272(10):6479-89.
20. Funhoff AM, Monge S, Teeuwen R, Koning GA, Schuurmans-Nieuwenbroek NM, Crommelin DJ, Haddleton DM, Hennink WE, van Nostrum CF. 2005. PEG shielded polymeric double-layered micelles for gene delivery. J Control Rel, 102(3):711-24.
21. Ganachaud F, Monteiro MJ, Gilbert RG, Dourges M, Thang SH, Rizzardo E. 2000. Molecular weight characterization of poly(N-isopropylacrylamide) prepared by living free-radical polymerization. Macromolecules, 33(18):6738-45.
22. Glasgow JN, Everts M, Curiel DT. 2006. Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther, 13(9):830-44.
23. Graham FL, van der Eb AJ. 1973. Transformation of rat cells by DNA of human adenovirus 5. Virology, 54(2):536-39.
24. Heskins M, Guillet J E. 1968. Solution properties of poly(N-isopropylacrylamide), J Macromol. Sci Chem, 2:1441-55.
25. Hinrichs WLJ, Schuurmans-Nieuwenbroek NME, van de Wetering P, Hennink WE. 1999. Thermosensitive polymers as carriers for DNA delivery. J Control Rel, 60(2-3):249-59.
26. Hwang JM, Fu KK, Phillips TL. 1998. Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol. Phys, 41(5):1099-111.
27. Kaplan JH, Pennington SE, St. George JA, Woodworth LA, Fasbender A, Marshall J, Cheng SH, Wadsworth SC, Gregory RJ, Smith AE. 1998. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum Gene Ther, 9(10):1469-79.
28. Kirn D. 2001. Clinical research results with d11520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther, 8(2):89-98.
29. Kombrabail MH, G. Krishnamoorthy G. 2005. Fluorescence dynamics of DNA condensed by the molecular crowding agent poly(ethylene glycol). J Fluoresc, 15(5):741-7.
30. Kurisawa M, Yokoyama M, Okano T. 2000. Transfection efficiency increases by incorporating hydrophobic monomer units into polymeric gene carriers. J Control Rel, 68(1):1-8.
31. Kurisawa M, Yokoyama M, Okano T. 2000. Gene expression control by temperature with thermo-responsive polymeric gene carriers. J Control Rel, 69(1):127-37
32. Lee AW, Sze WM, Yau TK, Yeung RM, Chappell R, Fowler JF. 2001. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol, 58(2):121-30.
33. Lee SB, Russell AJ, Matyjaszewski K. 2003. ATRP synthesis of amphiphilic random, gradient, and block copolymers of 2-(dimethylamino)ethyl methacrylate and n-butyl methacrylate in aqueous media. Biomacromolecules, 4(5): 1386-93.
34. Li JH, Chia M, Shi W, Ngo D, Strathdee CA, Huang D, Klamut H, Liu FF. 2002. Tumor-targeted gene therapy for nasopharyngeal carcinoma. Cancer Res, 62(1):171-8.
35. Liu FF. 2002. Novel gene therapy approach for nasopharyngeal carcinoma. Semin Cancer Biol, 12(6):505-15.
36. March KL, Madison JE, Trapnell BC. 1995. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum Gene Ther, 6(1):41-53.
37. Maizel Jr. JV, White DO, Scharff MD. 1968. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology, 36(1):115-25.
38. Mathias P, Wickham T, Moore M, Nemerow G. 1994. Multiple adenovirus serotypes use alpha v integrins for infection. J Virology. 68(10):6811-4.
39. Noureddini SC, Curiel DT. 2005. Genetic targeting strategies for adenovirus. Mol Pharm, 2(5):341-7.
40. Mok H, Palmer DJ, Ng P, Barry MA. 2005. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther, 11(1):66-79.
41. Moselhy J, Wu XY, Nicholov R, Kodaria K. 2000. In vitro studies of the interaction of poly(NIPAm/MAA) nanoparticles with proteins and cells. Biomater Sci Polymer Edn, 11(2):123-47.
42. O'Riordan CR, Lachapelle A, Delgado C, Parkes V, Wadsworth SC, Smith AE, Francis GE. 1999. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther, 10(8):1349-58.
43. Pirollo KF, Zon G, Rait A, Zhou Q, Yu W, Hogrefe R, Chang EH. 2006. Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther, 17(1):117-24.
44. Pirollo KF, Xu L, Non-viral gene delivery for p53. 2000. Curr Opin Mol Ther, 2(2):168-75.
45. Qi V, Weinrib L, Ma N, Li JH, Klamut H, Liu FF. 2001. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line. Int J Hyperthermia, 17(1):38-47.
46. Ramsay E, Gumbleton M. 2002. Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency. J Drug Target, 10(1):1-9.
47. Romanczuk CE, Zabner J, Barsomian G, Wadsworth SC, O'Riordan CR. 1999. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. Hum Gen Therapy, 10(16):2615-26.
48. Rungsardthong U, Deshpande M, Bailey L, Vamvakaki M, Armes SP, Garnett MC, Stolnik S. 2001. Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy. J Control Rel, 73(2-3):359-80.
49. Schild HG. 1992. Poly(N-isopropylacrylamide): experiment, theory and application. Prog Polym Sci, 17:163-249.
50. Shinozaki K, Suominen E, Carrick F, Sauter B, Kahari VM, Lierber A, Woo SL, Savontaus M. 2006. Efficient infection of tumor endothelial cells by a capsid-modified adenovirus. Gene Ther, 13(1):52-9.
51. Takeda N, Nakamura M, Yokoyama M, Okano T. 2004. Temperature-responsive polymeric carriers incorporating hydrophobic monomers for effective transfection in small doses. J Control Rel, 95(2):343-55.
52. Torchilin VP. 1996. Affinity liposomes in vivo: factors influencing target accumulation. J Mol Recognit, 9(5-6):335-46.
53. Twaites BR, de las Heras Alarcon C, Cunliffe D, Lavigne M, Pennadam S, Smith JR, Gorecki DC, Alexander C. 2004. Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J Control Rel, 97(3):551-66.
54. Twaites BR, de las Heras Alarcon C, Lavigne M, Saulnier A, Pennadam S, Cunliffe D, Gorecki DC, Alexander C. 2005. Thermoresponsive polymers as gene delivery vectors: cell viability, DNA transport and transfection studies. J Control Rel, 108(2-3):472-83.
55. van de Wetering P, Schuurmans-Nieuwenbroek NM, van Steenbergen MJ, D.J. Crommelin DJ, Hennink W.E. 2000. Copolymers of 2-(dimethylamino)ethyl methacrylate with ethoxytriethylene glycol methacrylate or N-vinyl-pyrrolidone as gene transfer agents. J Control Rel, 64(1-3):193-203.
56. Wakebayashi D, Nishiyama N, Itaka K, Miyata K, Yamasaki Y, Harada A, Koyama H, Nagasaki Y, Kataoka K. 2004. Polyion complex micelles of pDNA with acetal-poly(ethylene glycol)-poly(2-(dimethylamino)ethyl methacrylate) block copolymer as the gene carrier system: physico-chemical properties of micelles relevant to gene transfection efficacy. Biomacromolecules, 5(6):2128-36.
57. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell, 73(2), 309-19.
58. Wickham TJ, Roelvink PW, Brough DE, Kovesdi I. 1996. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nature Biotechnol, 14(11):1570-3.
59. Wickham TJ. 2000. Targeting adenovirus. Gene Ther, 7(2):110-4.
60. Volpers C, Kochanek S. 2004. Adenoviral vectors for gene transfer and therapy. J Gene Med, 6(1):S164-71.
61. Woodle MC, Scaria P, Ganesh S, Subramanian K, Titmas R, Cheng C, Yang J, Pan Y, Weng K, Gu C, Torkelson S. 2001. Sterically stabilized polyplex: ligand-mediated activity. J Control Release, 74(1-3):309-11.
62. Yu JH, Schaffer DV. 2005. Advanced targeting strategies for murine retroviral and adeno-associated viral vectors. Adv Biochem Eng Biotechnol, 99:147-67.